A case of cold agglutinin syndrome associated with chronic lymphocytic leukaemia harbouring mutations in CARD11 and KMT2D

Int J Hematol. 2023 Oct;118(4):472-476. doi: 10.1007/s12185-023-03608-9. Epub 2023 May 3.

Abstract

Cold agglutinin disease (CAD) is a rare cold autoimmune haemolytic anaemia (cAIHA) caused by IgM antibodies recognizing I antigens on erythrocytes. cAIHA is now mainly classified into two types: primary CAD and cold agglutinin syndrome (CAS). CAS develops in association with the underlying disease, which is most commonly malignant lymphoma. Recent studies have identified gene mutations in CARD11 and KMT2D in a high proportion of patients with CAD, which has led to recognition of CAD as an indolent lymphoproliferative disorder. We herein report a case of cAIHA without lymphocytosis or lymphadenopathy in whom bone marrow was infiltrated by a small population of clonal lymphocytes (6.8%) expressing cell surface markers consistent with chronic lymphocytic leukaemia (CLL). Whole-exome sequencing of bone marrow mononuclear cells revealed mutations in the CARD11 and KMT2D genes. This patient also had somatic hypermutation with overrepresentation of IGHV4-34, which is prevalent in CLL harbouring the KMT2D mutation. These observations suggest that CAS caused by early-phase CLL could be misinterpreted as primary CAD.

Keywords: Autoimmune haemolytic anaemia; CARD11; Cold agglutinin disease; KMT2D.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Hemolytic, Autoimmune* / complications
  • CARD Signaling Adaptor Proteins
  • Guanylate Cyclase
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / complications
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Lymphoproliferative Disorders*
  • Mutation

Substances

  • cold agglutinins
  • CARD11 protein, human
  • Guanylate Cyclase
  • CARD Signaling Adaptor Proteins